Not sure. I don't think it will matter either. For some reason they are not letting this thing trade and even cash value, they took a big pop in the pps away from retail, and somebody is obviously holding this down. But there are some on this board that this is normal, or this is how it should be trading. Goofy place it is....
The estimates are $ 2.80 (loss) for the 4th Quarter which were due to be out today. However, the released a PR yesterday announcing the year end 2018 to be released on April 2 so, don't know at this point if the 4th Qr will be released today as expected.
The company doesn't have any income simply because they still on the clinical trials but have enough cash to finish all of them going on so far.